Compressed air quality
Particle analysis methods and ISO 8573 Standard updates (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 13, 2019 Category: Pharmaceuticals Source Type: news
Pharma in review: trending stories 12/13/19
Most popular Pharma Manufacturing stories from the past seven days. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 13, 2019 Category: Pharmaceuticals Source Type: news
Lilly, Boehringer's Jardiance has heart failure trial setback
Boehringer Ingelheim and Eli Lilly announced failing results in two trials evaluating Jardiance in adults with chronic heart failure. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 13, 2019 Category: Pharmaceuticals Source Type: news
FDA oks Sarepta muscular dystrophy drug after previous rejection
The U.S. FDA granted an accelerated approval to Sarepta Therapeutics ' therapy for Duchenne muscular dystrophy, reversing its original rejection. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 13, 2019 Category: Pharmaceuticals Source Type: news
Digital transformation delayed
Should technology vendors shoulder some of the blame for pharma ’s digital stagnation? (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 12, 2019 Category: Pharmaceuticals Source Type: news
Trump nixes biologic protections in new trade deal
A new trade pact being negotiated between the U.S., Mexico and Canada has been stripped of provisions that would have protected drugmakers from biosimilar competition for at least a decade. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 11, 2019 Category: Pharmaceuticals Source Type: news
Correvio might look for buyer after FDA panel shoots down heart drug
Correvio Pharma Corp could hunt for a potential buyer now that its pivotal heart drug is not likely to win FDA approval. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 11, 2019 Category: Pharmaceuticals Source Type: news
J & amp;J CEO declines appearance at U.S. congressional hearing on talc carcinogens
According to the House of Representatives Subcommittee on Economic and Consumer Policy, Johnson& Johnson CEO Alex Gorsky declined to testify even after over a month of attempts to accommodate the company. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 10, 2019 Category: Pharmaceuticals Source Type: news
Sanofi, Regeneron restructure 12-year-old partnership
The existing collaboration relating to Dupixent (dupilumab), which recently reached $633 million in global sales, will remain unchanged following the restructuring (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 10, 2019 Category: Pharmaceuticals Source Type: news
Why labeling matters
How modern, centralized label management systems can give pharma companies an edge (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 10, 2019 Category: Pharmaceuticals Source Type: news
Execs face jail time for Samsung Biologics fraud
A court in South Korea has handed out prison sentences for three Samsung executives involved in accounting fraud at the company ’s biotech arm. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 9, 2019 Category: Pharmaceuticals Source Type: news
Merck makes big cancer buy with $2.7B ArQule deal
Another day — another big oncology deal in pharma. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 9, 2019 Category: Pharmaceuticals Source Type: news
Product Focus: Keepin' it clean
Innovations that make life easier in the cleanroom (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 9, 2019 Category: Pharmaceuticals Source Type: news
FDA removes hold on pivotal gene therapy trial
Abeona Therapeutics announced that the U.S. FDA has removed its clinical hold on the company ’s pivotal Phase 3 clinical trial evaluating gene therapy for the treatment of recessive dystrophic epidermolysis bullosa (RDEB). (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 9, 2019 Category: Pharmaceuticals Source Type: news
Sanofi to acquire Synthorx for $2.5B
Sanofi will acquire clinical-stage biotechnology company, Synthorx, for approximately $2.5 billion. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 9, 2019 Category: Pharmaceuticals Source Type: news
